Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF
NCT ID: NCT03061123
Last Updated: 2023-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
91 participants
OBSERVATIONAL
2015-09-30
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this investigation is to compare patient´s perceptions and physician´s assessments of benefits and risks of OAC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF
NCT03188211
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
NCT03259373
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
NCT06954610
Clinical Decision Support for Stroke Prevention in Atrial Fibrillation
NCT02635685
Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation
NCT03108872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New indication for oral anticoagulation (OAC)
* Ability of informed consent
Exclusion Criteria
* Valvular heart disease
* History of valve surgery
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LKH Feldbach
Feldbach, , Austria
LKH Fürstenfeld
Fürstenfeld, , Austria
Hospital Barmherzige Brueder Eggenberg
Graz, , Austria
Hospital Barmherzige Brueder Marschallgasse
Graz, , Austria
Hospital Elisabethinen
Graz, , Austria
Medical University of Graz
Graz, , Austria
LKH Hartberg
Hartberg, , Austria
Ordination Dr. Zweiker
Straden, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zweiker D, Zweiker R, Winkler E, Roesch K, Schumacher M, Stepan V, Krippl P, Bauer N, Heine M, Reicht G, Zweiker G, Sprenger M, Watzinger N. Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study. BMJ Open. 2017 Sep 25;7(9):e018242. doi: 10.1136/bmjopen-2017-018242.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
28-004 ex 15/16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.